Biogen Inc.BIIBNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+9.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+8.3%/yr
vs +5.8%/yr prior
5Y CAGR
+9.9%/yr
Consistent
Acceleration
+2.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.90B | +25.4% |
| 2024 | $2.31B | -8.8% |
| 2023 | $2.53B | +11.2% |
| 2022 | $2.28B | +8.0% |
| 2021 | $2.11B | +16.9% |
| 2020 | $1.81B | -7.7% |
| 2019 | $1.96B | +7.7% |
| 2018 | $1.82B | +11.4% |
| 2017 | $1.63B | +13.7% |
| 2016 | $1.43B | - |